VR as a Facilitator for Participation in Society Among Persons With MHD/SUD

Substance Use Disorders Clinical Trial

— SOPATMEDVR1  

Official title:

Complex Socio-emotional Learning in VR-based Simulation Training Among Persons With Mental Health and/or Substance Use Disorders"

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05653167
• Other study ID #: 326773VR_WP1
• Status: Active, not recruiting
• Start date: March 1, 2022
• Est. completion date: December 2024

Study information

• Verified date: November 2023
• Source: Sykehuset Innlandet HF
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is the first part of a larger project called "Virtual Reality (VR) as a facilitator for participation in society among persons with mental health/substance use disorders" in which aims to explore,develop and evaluate a VR-based paradigm that facilitates social participation and promotes social recovery of individuals with mental health and/or substance use disorders (MHD/SUD). The overall project comprises three work packages: an exploration study, a development study, and an evaluation study. This study will make up work package 1. The primary aim of this study (WP1) is to explore facilitators and barriers for participation in society among person with MHD/SUD, and to provide an understanding of mechanisms of social participation and social cohesion among persons with MHD/ SUD that may be affected by VR-based interventions. The investigators will derive a socio-emotional learning domain to facilitate key interpersonal and social processes among persons with MHD/SUD in VR-based interventions. To achieve the purpose of this study, the invistigators conduct 10 indepth interviews with service-user with MHD/SUD, 2 focus group interviews with 14 service-providers and an interview-survey with 100 service users. This gives the investigators the possibility to explore facilitators and barriers for social participation as experienced as by individuals with MHD/SUD and identify key interpersonal and social processes suitable to be addressed by tailored VR based interventions.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 124
• Est. completion date: December 2024
• Est. primary completion date: August 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• above 18 years of age
• receiving services in the municipality due to mental health and or addiction problems. Exclusion Criteria: -visual and hearing impairment, neurological disorders, and mental retardation [score =70 on the Test of Intelligence].

Related Conditions & MeSH terms

• Mental Disorder
• Mental Disorders
• Substance Use Disorders
• Substance-Related Disorders

Locations

Country	Name	City	State
Norway	Innlandet Hospital Trust	Brumunddal

Sponsors (2)

Lead Sponsor	Collaborator
Sykehuset Innlandet HF	Inland Norway University of Applied Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Practical and social functioning	measured by the Practical and Social Functioning Scale (PSF)	2 hours
Primary	Social inclusion	Measured by the Social and Community Opportunities Profile (SCOPE)	2 hours
Primary	Barriers for participation in society	This will be assessed within in-depth interviews	duration of the in-depth interview
Primary	Facilitators for participation in society	This will be assessed within in-depth interviews	duration of the in-depth interview